Frontiers | Cladribine treatment in chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: two case reports

The brief

Researchers have published two case reports on the use of Cladribine treatment in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN). CIDP and MMN are rare immune-mediated conditions affecting the peripheral nerves. The case reports were published in the Frontiers medical journal. The treatment involved Cladribine, a medication that has been used to treat certain autoimmune diseases. The reports provide new insights into the potential use of Cladribine in treating these conditions.

Auto-summarised from the full article